Educational information, not medical advice — ask your doctor or midwife.
Gynostemma is a leafy vine from the cucumber family, native to the mountain regions of southern China, Korea, Japan, and Southeast Asia. It has been consumed as a daily tea in parts of China's Guizhou province — an area historically noted for exceptional longevity — for hundreds of years. Unlike true ginseng, it is inexpensive and widely accessible, earning it the nickname 'Poor Man's Ginseng.'
Gynostemma's primary active compounds are gypenosides — a large family of saponins structurally similar to ginsenosides found in ginseng. These compounds help regulate blood sugar by improving insulin sensitivity, support the liver's ability to manage cholesterol production, and help the body adapt to physical and emotional stress. It also activates AMPK, a key enzyme in the body that acts like a metabolic master switch, helping cells use energy more efficiently.
Traditional use favors dried leaf tea, which is mild, slightly sweet, and easy to drink daily. Capsules and standardized extracts offer more precise dosing for specific health goals. Tinctures and powders provide flexible options for blending into smoothies or other drinks. For metabolic goals like blood sugar and cholesterol, standardized extracts tend to deliver more reliable results.
Gynostemma first came to wider attention in the 1970s when Japanese researchers surveying traditional longevity regions discovered it consumed daily by populations with unusually long lifespans. Formal scientific study began in earnest in the 1980s, with Chinese and Japanese researchers documenting its adaptogenic, lipid-lowering, and blood-sugar-regulating properties. It remains an important herb in Chinese folk medicine and is increasingly recognized in integrative and functional medicine globally.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.